Literature DB >> 3468465

Acute suppurative parotitis in outpatients: microbiologic and posttreatment sialographic findings.

P J Lamey, M A Boyle, T W MacFarlane, L P Samaranayake.   

Abstract

The presenting clinical features of twenty-seven cases of acute suppurative parotitis seen in the Oral Medicine Unit, Glasgow Dental Hospital, between 1975 and 1985 are reviewed. The microbiologic findings plus the management and subsequent findings on sialography after recovery are summarized. Of the microorganisms isolated, alpha-hemolytic streptococci predominated, with many other bacteria similar in range to those reported in previous studies. Microbiologically, the drug of choice was erythromycin, closely followed by ampicillin. Sialography in the posttreatment phase demonstrated a local salivary gland abnormality in 70% of patients, and 22% of patients had a generalized salivary gland disorder. On the basis of these findings, a management regime for patients with acute suppurative parotitis is suggested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3468465     DOI: 10.1016/0030-4220(87)90337-9

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  3 in total

1.  Neonatal suppurative parotitis: a vanishing disease?

Authors:  A Coban; Z Ince; R Uçsel; A Ozgeneci; G Can
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

2.  The Oral Bacterium Fusobacterium nucleatum Binds Staphylococcus aureus and Alters Expression of the Staphylococcal Accessory Regulator sarA.

Authors:  Bruno P Lima; Linda I Hu; Gerrit W Vreeman; Douglas B Weibel; Renate Lux
Journal:  Microb Ecol       Date:  2018-11-24       Impact factor: 4.552

3.  Antimicrobial Efficacy of Herbal and Chlorhexidine Mouthrinse against Staphylococcus aureus - An in vitro Microbiological Study.

Authors:  Nagappan Nagappan; Kamalashankar Palaneeswaran; Kannan Kumarappan; Raghunathan Natarajan; Rameezuddin Tajuddin; Yalamanchi Anusha
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.